Ligand profile
HBJ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03495 — Histone deacetylase superfamily protein
Identifiers
Database identifiers and provenance.
- Ligand ID
HBJ- PDB
6dvm- UniProt (similar protein)
F8W4B7- Target protein
- KP13_03495
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 102.0
- −1 ≤ LogP ≤ 5 3.46
- MW ≤ 500 Da 460.5
- LogP ≤ 5 3.46
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 102.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc(cc1)NC(=O)CN(Cc2ccc(cc2)C(=O)NO)C(=O)c3ccc(cc3)N(C)CCc1ccc(cc1)NC(=O)CN(Cc2ccc(cc2)C(=O)NO)C(=O)c3ccc(cc3)N(C)C
InChI=1S/C26H28N4O4/c1-18-4-12-22(13-5-18)27-24(31)17-30(16-19-6-8-20(9-7-19)25(32)28-34)26(33)21-10-14-23(15-11-21)29(2)3/h4-15,34H,16-17H2,1-3H3,(H,27,31)(H,28,32)InChI=1S/C26H28N4O4/c1-18-4-12-22(13-5-18)27-24(31)17-30(16-19-6-8-20(9-7-19)25(32)28-34)26(33)21-10-14-23(15-11-21)29(2)3/h4-15,34H,16-17H2,1-3H3,(H,27,31)(H,28,32)
UEKPDDMOEDHDCS-UHFFFAOYSA-NUEKPDDMOEDHDCS-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00850
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand HBJ →
- PDB RCSB structure 6dvm →
- UniProt UniProt F8W4B7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “HBJ”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03495.
PDB 45
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 55
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).